Prevalence and characteristics of myocardial bridging in coronary angiogram--data from consecutive 5525 patients

Ju-Ying Qian1, Feng Zhang, Min Dong

  • 1Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai 200032, China.

Insights

Myocardial bridging (MB) is a frequent finding in coronary angiograms, with a 16.1% incidence. Treatments like nitroglycerin and stenting can increase MB compression and length.

Area of Science:

  • Cardiology
  • Diagnostic Imaging

Background:

  • Discrepancies in myocardial bridging (MB) incidence exist between postmortem and angiographic studies.
  • This study aimed to determine the prevalence and angiographic characteristics of MB.

Purpose of the Study:

  • To investigate the prevalence of myocardial bridging (MB) in a large cohort undergoing coronary angiography.
  • To analyze the angiographic characteristics of MB, including its response to nitroglycerin and stenting.

Main Methods:

  • 5525 patients undergoing coronary angiography were analyzed.
  • MB was identified by the 'milking effect' during systole.
  • Angiography was repeated after nitroglycerin administration and, in some cases, after stenting for proximal stenosis.

Main Results:

  • Myocardial bridging (MB) was identified in 16.1% of patients (888/5525).
  • Atherosclerotic lesions were more common proximal to MB (40.3%) than distal (5.5%).
  • Nitroglycerin and stenting significantly increased MB systolic compression and length.

Conclusions:

  • Myocardial bridging (MB) is a common finding in coronary angiograms.
  • Intracoronary nitroglycerin and proximal stenting enhance MB's angiographic appearance.
  • These interventions may unmask or accentuate MB characteristics.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...